Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Venus Concept (VERO) has issued an update.
On May 24, 2024, Venus Concept Inc. and its subsidiary, Venus Concept USA, Inc., struck a deal with Madryn Health Partners, LP, and its affiliate to swap $35 million of existing loan debt for newly issued convertible notes and shares of preferred stock. The transaction, which introduces “Series Y Convertible Preferred Stock” priced at $60.66 per share, aims to smooth out financial obligations while setting the stage for a shareholder meeting to address stock convertibility under Nasdaq rules. The preferred stock comes with rights and restrictions, including conversion terms, liquidation preferences, and voting limitations, outlined in a detailed Certificate of Designations filed with the state of Delaware.
For a thorough assessment of VERO stock, go to TipRanks’ Stock Analysis page.
